John P. Hamill

Insider Reports History

Location
Doylestown, PA
Signature
/s/ John Hamill
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John P. Hamill:

Form 4 holding SrVP/CFO/Prin Fin & Acct Ofcr

Aprea Therapeutics, Inc.

Security class
Pre-Funded Warrant
Shares / value
30,978
Estimated value
$24,999
Report date
31 Mar 2026
Price
$0.8070
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SrVP/CFO/Prin Fin & Acct Ofcr

Aprea Therapeutics, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
40,380
Estimated value
Report date
12 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John P. Hamill

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .